News

YSOPIA Bioscience secures €1.55M in non-dilutive funding from Bpifrance and the European Regional Development Fund

Nov 17, 2020
  • Bpifrance renews its support for YSOPIA through its Innovation Development Funding (Aide pour le développement de l’innovation) program

  • The European Regional Development Fund (ERDF) supports YSOPIA through France’s Nouvelle-Aquitaine Region

Bordeaux (France), November 16, 2020 – YSOPIA Bioscience, a French biotech company harnessing the properties of keystone single-strain bacteria to develop groundbreaking microbiome-based biotherapies, today announced that it has received funding approval from Bpifrance and the European Regional Development Fund through Nouvelle-Aquitaine Region for a total of €1.55M. This new funding will help drive YSOPIA’s biotherapeutics pipeline forward.

The company will receive €0.75M in funding from Bpifrance and a €0.8M grant from the Nouvelle-Aquitaine Region as part of an EU program to support regional competitiveness (ERDF). This funding will be used to advance the clinical development of the company’s lead biotherapy, Xla1, targeting obesity and associated metabolic diseases, and to support the preclinical development of another candidate addressing inflammatory bowel diseases (IBD). YSOPIA received initial funding from Bpifrance and the Nouvelle-Aquitaine Region in 2019.

“We are very grateful to Bpifrance and the Nouvelle-Aquitaine Region for their lasting, long-term support. Our regional ecosystem is very active in fostering innovative projects, and our approach in developing single-strain keystone bacteria as biotherapies addressing chronic diseases is a cutting-edge innovation. With our entry into the clinical phase, we have moved one step closer to becoming a world-leading biotech in the development of game-changing microbiome-based biotherapies,” said Georges Rawadi, CEO of YSOPIA Bioscience.

 

About Bpifrance

Bpifrance is the French national investment bank: it finances businesses – at every stage of their development – through loans, guarantees, equity investments and export insurances. Bpifrance also provides extra financial services (training, consultancy) to help entrepreneurs grow their businesses and overcome the challenges they face (innovation, export…).
For more information, please visit our website:  www.bpifrance.fr and presse.bpifrance.fr   
Follow us on Twitter: @Bpifrance –  @BpifrancePresse

In the same category

News

We are looking for a R&D Microbiologist

Oct 13, 2020

more +
News

LNC Therapeutics becomes YSOPIA Bioscience marking its transition to a clinical stage company

Sep 29, 2020

more +
News

LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial...

Sep 8, 2020

more +

YSOPIA Bioscience © 2020 - all rights reserved terms and conditions